- Home
- PRQR vs TROO Comparison
PRQR vs TROO Comparison
Compare PRQR & TROO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PRQR | TROO |
|---|---|---|
| Founded | 2012 | 2005 |
| Country | Netherlands | Hong Kong |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Radio And Television Broadcasting And Communications Equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 262.5M | 287.1M |
| IPO Year | 2014 | 2008 |
Fundamental Metrics
Financial Performance| Metric | PRQR | TROO |
|---|---|---|
| Price | $1.63 | $1.74 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 9 | 0 |
| Target Price | ★ $8.22 | N/A |
| AVG Volume (30 Days) | ★ 511.7K | 242.1K |
| Earning Date | 11-05-2026 | 10-16-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $9.20 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.33 | $1.02 |
| 52 Week High | $3.10 | $5.28 |
Technical Indicators
Market Signals| Indicator | PRQR | TROO |
|---|---|---|
| Relative Strength Index (RSI) | 31.81 | N/A |
| Support Level | $1.64 | N/A |
| Resistance Level | $1.99 | N/A |
| Average True Range (ATR) | 0.08 | 0.00 |
| MACD | -0.02 | 0.00 |
| Stochastic Oscillator | 10.00 | 0.00 |
Price Performance
Historical ComparisonAbout PRQR ProQR Therapeutics N.V.
ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics. Geographically, the company operates in United States.
About TROO TROOPS Inc.
TROOPS Inc is a conglomerate group of various businesses with its headquarters based in Hong Kong. The group is principally engaged in money lending business in Hong Kong providing mortgage loans to high quality target borrowers, property investment to generate additional rental income and the development, operation and management of an online financial marketplace that provides one-stop financial technology solutions including API services by leveraging artificial intelligence, large data and blockchain, and cloud computing (SaaS). It derives revenue from Hong Kong and Australia. Majority of its revenue generates from domestic market.